Substance P and IgE-Mediated Allergy II. Reduction of Rhesus IgE Antibody after Aerosol Exposure to Substance P and Allergen
Experiments were designed to evaluate the effect of aerosolized Substance P (SP) and ascaris antigen (A) on airway responses of rhesus monkeys that had IgE antibody against A. During the course of these experiments, a totally unplanned and unexpected observation was made: this was a decline in IgE antibody, as determined by quantitative end-point dilution titers, in the group of animals that had received aerosolized SP and A. Our experience with this species of primate over 2 decades had shown that IgE-mediated cutaneous reactivity persists in the monkeys (as in man) for years with little change. The decline in IgE antibody titers in monkeys occurred over a few weeks to months, was related to the aerosol exposure to SP and A, and has persisted with minimal to moderate rise in IgE antibody. Although these results had to be analyzed retrospectively, the changes were significant by statistical analysis. This serendipitous observation suggests a possible means of reducing IgE antibodies therapeutically in primates. A theory of why primates may develop IgE antibody to antigens absorbed through mucosal surfaces is proposed.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
Document Type: Research Article
Publication date: 1993-01-01
More about this publication?
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Ingenta Connect is not responsible for the content or availability of external websites